Investment area
Bioindustrial Investments
Growth Investments
Region
North America
Date of investment
April 2022
Elo is dedicated to improving human health and wellness through food by integrating technologies and enabling efficient food production systems.
Contact
Stephen van Helden
Principal
Departments: Growth Investments, Novo Holdings Equity US Inc., Bioindustrial Investments
Stephen joined Novo Holdings in 2022.
Prior to joining Novo Holdings, Stephen spent over 5 years developing new products, partnerships and businesses at The Production Board as an EIR, and Zymergen where he led many Industrial efforts including across Agriculture, Food and Packaging. He previously worked with McKinsey and Company as an Associate Partner across a number of sectors and geographies.
Stephen holds an MBA from Stanford University and a BSc in Electrical Engineering from the University of Cape Town.
